Nonsurgical treatments for prostate cancer include androgen-deprivation therapy (ADT),
radiation therapy (RT), ablative therapies, chemotherapy, and newly emerging …

A systematic review of radiation therapy trials in prostate cancer has been performed
according to principles adopted by the Swedish Council of Technology Assessment in …

PURPOSE: To compare the performance of T2-weighted (T2w) imaging and dynamic
contrast-enhanced (DCE) magnetic resonance imaging (MRI) of the prostate gland in the …

The primary study objective was to determine the safety of intraprostatic administration of a
replication-competent, oncolytic adenovirus containing a cytosine deaminase (CD)/herpes …

Purpose: To determine the significance of prostate-specific antigen (PSA) nadir (nPSA) and
the time to nPSA (TnPSA) in predicting biochemical or clinical disease-free survival (PSA …

Replication-competent adenovirus-mediated suicide gene therapy is an investigational
cancer treatment in which an oncolytic adenovirus armed with chemo-radiosensitizing …

Purpose: A positive biopsy after external beam radiotherapy in patients free of any evidence
of treatment failure is not synonymous with eventual recurrence. Although biopsy positivity is …

Prostate cancer is the most commonly diagnosed non-cutaneous neoplasm in men in the
United States and the second leading cause of cancer mortality. One in 7 men will be …

Intensity-modulated radiotherapy represents a recent advancement in conformal
radiotherapy. It employs specialized computer-driven technology to generate dose …

PURPOSE: To evaluate the effect of 3 months vs. 8 months of neoadjuvant hormonal
therapy before conventional dose radiotherapy (RT) on disease-free survival using prostate …